Terms: = Endocrine gland cancer AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA AND Prognosis
3 results:
1. MS: wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer.
Yin S; Yang L; Zheng Y; Zang R
J Ovarian Res; 2022 May; 15(1):56. PubMed ID: 35538489
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
Hirata Y; Murai N; Yanaihara N; Saito M; Saito M; Urashima M; Murakami Y; Matsufuji S; Okamoto A
BMC Cancer; 2014 Nov; 14():799. PubMed ID: 25366985
[TBL] [Abstract] [Full Text] [Related]
3. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of ppm1d and APPBP2 as likely amplification targets.
Hirasawa A; Saito-Ohara F; Inoue J; Aoki D; Susumu N; Yokoyama T; Nozawa S; Inazawa J; Imoto I
Clin Cancer Res; 2003 Jun; 9(6):1995-2004. PubMed ID: 12796361
[TBL] [Abstract] [Full Text] [Related]
